Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 4 The grey zone between active

Published byLinnéa Lindberg Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 4 The grey zone between active"— Presentation transcript:

1 Figure 4 The grey zone between active
surveillance (AS) and watchful waiting based on expert consensus Figure 4 | The grey zone between active surveillance (AS) and watchful waiting based on expert consensus. This grey zone was described by the experts as a phase of active (regular) annual monitoring of serum PSA levels (no biopsies undertaken) with the aim of palliation when deemed necessary. Bruinsma, S. M. et al. (2017) Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure Nat. Rev. Urol. doi: /nrurol

Download ppt "Figure 4 The grey zone between active"

Similar presentations

Introduction The incidence of prostate cancer in Asians is lower compared to the Westerners in men with PSA

Introduction The incidence of prostate cancer in Asians is lower compared to the Westerners in men with PSA
Tyrosine kinase signalling (review) TGF signalling Notch signalling.

Tyrosine kinase signalling (review) TGF signalling Notch signalling.
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.

Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
PSA Shared Care Jim Wood. Background A significant number of men with prostate cancer (CaP) are receiving regular hospital follow up (out- patient visits),

PSA Shared Care Jim Wood. Background A significant number of men with prostate cancer (CaP) are receiving regular hospital follow up (out- patient visits),
Overdetection of prostate cancer ESMO Brussel 2007 Chris H.Bangma Erasmus University Medical Centre Rotterdam, The Netherlands.

Overdetection of prostate cancer ESMO Brussel 2007 Chris H.Bangma Erasmus University Medical Centre Rotterdam, The Netherlands.
Bibliografia 1. Djavan, B., Ravery, V., Zlotta, A. et al: Prospective evaluation of Prostate cancer detected on biopsies 1, 2, 3 and 4: When should we.

Bibliografia 1. Djavan, B., Ravery, V., Zlotta, A. et al: Prospective evaluation of Prostate cancer detected on biopsies 1, 2, 3 and 4: When should we.
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 4 Types of urinary diversion

Figure 4 Types of urinary diversion
Figure 1 Male infertility and assisted reproduction globally

Figure 1 Male infertility and assisted reproduction globally
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 2 Recruitment of experts to the Delphi study

Figure 2 Recruitment of experts to the Delphi study
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 1 The UMBRELLA SIOP-RTSG 2016 protocol logo

Figure 1 The UMBRELLA SIOP-RTSG 2016 protocol logo
Figure 1 Cellular processes involved in cancer development

Figure 1 Cellular processes involved in cancer development
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 3 Semantic model of the active surveillance (AS) timeline

Figure 3 Semantic model of the active surveillance (AS) timeline

Similar presentations

Ads by Google